Development of Antimicrobial Stapled Peptides Based on Magainin 2 Sequence

Magainin 2 (Mag2), which was isolated from the skin of the African clawed frog, is a representative antimicrobial peptide (AMP) that exerts antimicrobial activity via microbial membrane disruption. It has been reported that the helicity and amphipathicity of Mag2 play important roles in its antimicr...

Full description

Saved in:
Bibliographic Details
Published inMolecules (Basel, Switzerland) Vol. 26; no. 2; p. 444
Main Authors Hirano, Motoharu, Saito, Chihiro, Yokoo, Hidetomo, Goto, Chihiro, Kawano, Ryuji, Misawa, Takashi, Demizu, Yosuke
Format Journal Article
LanguageEnglish
Published Switzerland MDPI AG 16.01.2021
MDPI
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Magainin 2 (Mag2), which was isolated from the skin of the African clawed frog, is a representative antimicrobial peptide (AMP) that exerts antimicrobial activity via microbial membrane disruption. It has been reported that the helicity and amphipathicity of Mag2 play important roles in its antimicrobial activity. We investigated and recently reported that 17 amino acid residues of Mag2 are required for its antimicrobial activity, and accordingly developed antimicrobial foldamers containing α,α-disubstituted amino acid residues. In this study, we further designed and synthesized a set of Mag2 derivatives bearing the hydrocarbon stapling side chain for helix stabilization. The preferred secondary structures, antimicrobial activities, and cell-membrane disruption activities of the synthesized peptides were evaluated. Our analyses revealed that hydrocarbon stapling strongly stabilized the helical structure of the peptides and enhanced their antimicrobial activity. Moreover, peptide 2 stapling between the first and fifth position from the N-terminus showed higher antimicrobial activity than that of Mag2 against both gram-positive and gram-negative bacteria without exerting significant hemolytic activity. To investigate the modes of action of tested peptides 2 and 8 in antimicrobial and hemolytic activity, electrophysiological measurements were performed.
AbstractList Magainin 2 ( ), which was isolated from the skin of the African clawed frog, is a representative antimicrobial peptide (AMP) that exerts antimicrobial activity via microbial membrane disruption. It has been reported that the helicity and amphipathicity of play important roles in its antimicrobial activity. We investigated and recently reported that 17 amino acid residues of are required for its antimicrobial activity, and accordingly developed antimicrobial foldamers containing α,α-disubstituted amino acid residues. In this study, we further designed and synthesized a set of derivatives bearing the hydrocarbon stapling side chain for helix stabilization. The preferred secondary structures, antimicrobial activities, and cell-membrane disruption activities of the synthesized peptides were evaluated. Our analyses revealed that hydrocarbon stapling strongly stabilized the helical structure of the peptides and enhanced their antimicrobial activity. Moreover, peptide stapling between the first and fifth position from the -terminus showed higher antimicrobial activity than that of against both gram-positive and gram-negative bacteria without exerting significant hemolytic activity. To investigate the modes of action of tested peptides and in antimicrobial and hemolytic activity, electrophysiological measurements were performed.
Magainin 2 (Mag2), which was isolated from the skin of the African clawed frog, is a representative antimicrobial peptide (AMP) that exerts antimicrobial activity via microbial membrane disruption. It has been reported that the helicity and amphipathicity of Mag2 play important roles in its antimicrobial activity. We investigated and recently reported that 17 amino acid residues of Mag2 are required for its antimicrobial activity, and accordingly developed antimicrobial foldamers containing α,α-disubstituted amino acid residues. In this study, we further designed and synthesized a set of Mag2 derivatives bearing the hydrocarbon stapling side chain for helix stabilization. The preferred secondary structures, antimicrobial activities, and cell-membrane disruption activities of the synthesized peptides were evaluated. Our analyses revealed that hydrocarbon stapling strongly stabilized the helical structure of the peptides and enhanced their antimicrobial activity. Moreover, peptide 2 stapling between the first and fifth position from the N-terminus showed higher antimicrobial activity than that of Mag2 against both gram-positive and gram-negative bacteria without exerting significant hemolytic activity. To investigate the modes of action of tested peptides 2 and 8 in antimicrobial and hemolytic activity, electrophysiological measurements were performed.
Magainin 2 (Mag2), which was isolated from the skin of the African clawed frog, is a representative antimicrobial peptide (AMP) that exerts antimicrobial activity via microbial membrane disruption. It has been reported that the helicity and amphipathicity of Mag2 play important roles in its antimicrobial activity. We investigated and recently reported that 17 amino acid residues of Mag2 are required for its antimicrobial activity, and accordingly developed antimicrobial foldamers containing α,α-disubstituted amino acid residues. In this study, we further designed and synthesized a set of Mag2 derivatives bearing the hydrocarbon stapling side chain for helix stabilization. The preferred secondary structures, antimicrobial activities, and cell-membrane disruption activities of the synthesized peptides were evaluated. Our analyses revealed that hydrocarbon stapling strongly stabilized the helical structure of the peptides and enhanced their antimicrobial activity. Moreover, peptide 2 stapling between the first and fifth position from the N-terminus showed higher antimicrobial activity than that of Mag2 against both gram-positive and gram-negative bacteria without exerting significant hemolytic activity. To investigate the modes of action of tested peptides 2 and 8 in antimicrobial and hemolytic activity, electrophysiological measurements were performed.Magainin 2 (Mag2), which was isolated from the skin of the African clawed frog, is a representative antimicrobial peptide (AMP) that exerts antimicrobial activity via microbial membrane disruption. It has been reported that the helicity and amphipathicity of Mag2 play important roles in its antimicrobial activity. We investigated and recently reported that 17 amino acid residues of Mag2 are required for its antimicrobial activity, and accordingly developed antimicrobial foldamers containing α,α-disubstituted amino acid residues. In this study, we further designed and synthesized a set of Mag2 derivatives bearing the hydrocarbon stapling side chain for helix stabilization. The preferred secondary structures, antimicrobial activities, and cell-membrane disruption activities of the synthesized peptides were evaluated. Our analyses revealed that hydrocarbon stapling strongly stabilized the helical structure of the peptides and enhanced their antimicrobial activity. Moreover, peptide 2 stapling between the first and fifth position from the N-terminus showed higher antimicrobial activity than that of Mag2 against both gram-positive and gram-negative bacteria without exerting significant hemolytic activity. To investigate the modes of action of tested peptides 2 and 8 in antimicrobial and hemolytic activity, electrophysiological measurements were performed.
Magainin 2 ( Mag2 ), which was isolated from the skin of the African clawed frog, is a representative antimicrobial peptide (AMP) that exerts antimicrobial activity via microbial membrane disruption. It has been reported that the helicity and amphipathicity of Mag2 play important roles in its antimicrobial activity. We investigated and recently reported that 17 amino acid residues of Mag2 are required for its antimicrobial activity, and accordingly developed antimicrobial foldamers containing α,α-disubstituted amino acid residues. In this study, we further designed and synthesized a set of Mag2 derivatives bearing the hydrocarbon stapling side chain for helix stabilization. The preferred secondary structures, antimicrobial activities, and cell-membrane disruption activities of the synthesized peptides were evaluated. Our analyses revealed that hydrocarbon stapling strongly stabilized the helical structure of the peptides and enhanced their antimicrobial activity. Moreover, peptide 2 stapling between the first and fifth position from the N -terminus showed higher antimicrobial activity than that of Mag2 against both gram-positive and gram-negative bacteria without exerting significant hemolytic activity. To investigate the modes of action of tested peptides 2 and 8 in antimicrobial and hemolytic activity, electrophysiological measurements were performed.
Author Kawano, Ryuji
Demizu, Yosuke
Saito, Chihiro
Yokoo, Hidetomo
Misawa, Takashi
Hirano, Motoharu
Goto, Chihiro
AuthorAffiliation 3 Department of Biotechnology and Life Science, Tokyo University of Agriculture and Technology, 2-24-6 Naka-cho, Koganei, Tokyo 184-8588, Japan; c-saito@st.go.tuat.ac.jp (C.S.); rjkawano@cc.tuat.ac.jp (R.K.)
2 Graduate School of medical Life Science, Yokohama City University, 1-7-29, Yokohama, Kanagawa 230-0045, Japan
1 Division of Organic Chemistry, National Institute of Health Sciences, 3-25-26, Tonomachi, Kawasaki, Kanagawa 210-9501, Japan; w205435g@yokohama-cu.ac.jp (M.H.); yokoo@nihs.go.jp (H.Y.); w195412a@yokohama-cu.ac.jp (C.G.)
AuthorAffiliation_xml – name: 1 Division of Organic Chemistry, National Institute of Health Sciences, 3-25-26, Tonomachi, Kawasaki, Kanagawa 210-9501, Japan; w205435g@yokohama-cu.ac.jp (M.H.); yokoo@nihs.go.jp (H.Y.); w195412a@yokohama-cu.ac.jp (C.G.)
– name: 3 Department of Biotechnology and Life Science, Tokyo University of Agriculture and Technology, 2-24-6 Naka-cho, Koganei, Tokyo 184-8588, Japan; c-saito@st.go.tuat.ac.jp (C.S.); rjkawano@cc.tuat.ac.jp (R.K.)
– name: 2 Graduate School of medical Life Science, Yokohama City University, 1-7-29, Yokohama, Kanagawa 230-0045, Japan
Author_xml – sequence: 1
  givenname: Motoharu
  surname: Hirano
  fullname: Hirano, Motoharu
– sequence: 2
  givenname: Chihiro
  surname: Saito
  fullname: Saito, Chihiro
– sequence: 3
  givenname: Hidetomo
  surname: Yokoo
  fullname: Yokoo, Hidetomo
– sequence: 4
  givenname: Chihiro
  surname: Goto
  fullname: Goto, Chihiro
– sequence: 5
  givenname: Ryuji
  orcidid: 0000-0001-6523-0649
  surname: Kawano
  fullname: Kawano, Ryuji
– sequence: 6
  givenname: Takashi
  surname: Misawa
  fullname: Misawa, Takashi
– sequence: 7
  givenname: Yosuke
  orcidid: 0000-0001-7521-4861
  surname: Demizu
  fullname: Demizu, Yosuke
BackLink https://www.ncbi.nlm.nih.gov/pubmed/33466998$$D View this record in MEDLINE/PubMed
BookMark eNp9kl1rFTEQhhep2A_9Ad7IgjfeHJ18bZIbodavSkWheh2y2ckxh2xyutkt-O9Ne2ppK0gukkme92UyM4fNXsoJm-Y5gdeMaXgz5ohuiVhoBxQ454-aA8IprBhwvXfnvN8clrIBoIQT8aTZZ4x3ndbqoPnyHi8x5u2IaW6zb4_THMbgptwHG9vz2W4jDu133M5hwNK-s6WGObVf7dqGFFJL23O8WDA5fNo89jYWfHazHzU_P374cfJ5dfbt0-nJ8dnKCaHnFdWilxq8A2qZ9lpR6aDzvQSnOukZQemhB9kpoQlVwhIUXtuBcYeU-IEdNac73yHbjdlOYbTTb5NtMNcXeVobO83BRTSCM8Kcwn6Qineqt8oCSAJc9eic19Xr7c5ru_QjDq5WYbLxnun9lxR-mXW-NFIxqKsavLoxmHItQ5nNGIrDGG3CvBRDudScUsFpRV8-QDd5mVIt1TUlFNQGVerF3YxuU_nbsgqQHVCbVMqE_hYhYK7GwvwzFlUjH2hcmO0c8tWnQvyP8g_iuL5t
CitedBy_id crossref_primary_10_1016_j_bmcl_2024_129794
crossref_primary_10_1007_s00726_023_03245_w
crossref_primary_10_1098_rsos_211583
crossref_primary_10_1002_psc_3551
crossref_primary_10_3390_antibiotics11101338
crossref_primary_10_3390_antibiotics11020273
crossref_primary_10_1248_yakushi_22_00115
crossref_primary_10_3390_antibiotics12010019
crossref_primary_10_3390_pharmaceutics13060773
crossref_primary_10_3390_ijms25169109
crossref_primary_10_1016_j_bpc_2022_106759
crossref_primary_10_1186_s40779_021_00343_2
crossref_primary_10_1039_D3DD00090G
crossref_primary_10_1007_s10989_024_10623_9
crossref_primary_10_1007_s40495_023_00342_y
crossref_primary_10_1016_j_drudis_2025_104305
crossref_primary_10_1016_j_ejmech_2025_117445
crossref_primary_10_1080_17460441_2024_2350568
crossref_primary_10_1016_j_phrs_2024_107137
crossref_primary_10_3390_antibiotics12081326
crossref_primary_10_1007_s00726_021_02995_9
crossref_primary_10_1016_j_biochi_2024_12_007
crossref_primary_10_1021_acsinfecdis_4c00115
crossref_primary_10_3390_pharmaceutics15031005
crossref_primary_10_37349_eds_2024_00041
crossref_primary_10_1021_acs_jcim_2c01419
crossref_primary_10_3390_mi14020373
crossref_primary_10_2139_ssrn_4174572
crossref_primary_10_1039_D3SC04124G
crossref_primary_10_3390_biom11050761
crossref_primary_10_1021_acschembio_3c00411
crossref_primary_10_3390_cimb47010001
crossref_primary_10_3390_pharmaceutics16121542
crossref_primary_10_1016_j_ejmech_2023_115377
crossref_primary_10_3390_ijms22105364
crossref_primary_10_3390_antibiotics10121499
crossref_primary_10_3390_antibiotics12091400
crossref_primary_10_2174_0113892010194428231017051836
crossref_primary_10_36691_RJA15038
Cites_doi 10.1146/annurev.biochem.78.082907.145923
10.1021/acsomega.9b01033
10.1038/srep01995
10.1016/j.csbj.2019.01.012
10.1038/35007145
10.1021/bc500408p
10.1021/acs.jmedchem.5b00537
10.1021/acs.jmedchem.9b02025
10.1016/j.bbamem.2006.02.032
10.1038/nchem.2779
10.1128/MMBR.00039-14
10.1039/C9MD00166B
10.1038/s41587-019-0222-z
10.1126/science.1099191
10.1021/acsabm.8b00835
10.1002/tcr.202000047
10.1039/C8AN00243F
10.1016/j.bpc.2015.02.005
10.1038/srep33003
10.1002/psc.2780
10.3390/ijms19103041
10.1002/cmdc.201900460
ContentType Journal Article
Copyright 2021. This work is licensed under http://creativecommons.org/licenses/by/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
2021 by the authors. 2021
Copyright_xml – notice: 2021. This work is licensed under http://creativecommons.org/licenses/by/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
– notice: 2021 by the authors. 2021
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7X7
7XB
88E
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BENPR
CCPQU
DWQXO
FYUFA
GHDGH
K9.
M0S
M1P
PHGZM
PHGZT
PIMPY
PJZUB
PKEHL
PPXIY
PQEST
PQQKQ
PQUKI
PRINS
7X8
5PM
DOA
DOI 10.3390/molecules26020444
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
ProQuest Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials
ProQuest Central
ProQuest One
ProQuest Central Korea
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Health & Medical Complete (Alumni)
Health & Medical Collection (Alumni)
Medical Database
ProQuest Central Premium
ProQuest One Academic
Publicly Available Content Database
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Publicly Available Content Database
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Central China
ProQuest Central
ProQuest Health & Medical Research Collection
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
Health & Medical Research Collection
ProQuest Central (New)
ProQuest Medical Library (Alumni)
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Hospital Collection (Alumni)
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest One Academic UKI Edition
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList MEDLINE
Publicly Available Content Database
MEDLINE - Academic


CrossRef
Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 4
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Chemistry
EISSN 1420-3049
ExternalDocumentID oai_doaj_org_article_54313c8ebd78468ba8a0071048beccf9
PMC7830303
33466998
10_3390_molecules26020444
Genre Journal Article
GrantInformation_xml – fundername: the NOVARTIS Foundation (Japan) for the Promotion of Science
  grantid: Y.D.
– fundername: TERUMO FOUNDATION for Life Sciences and ARTS
  grantid: Y.D.
– fundername: the Sumitomo Foundation
  grantid: Y.D.
– fundername: Japan Agency for Medical Research and Development
  grantid: 20mk0101120j0003
– fundername: Japan Society for the Promotion of Science
  grantid: 20k22711, H.Y.; 18k14880, T.M.; 17k08385 and 18H05502, Y.D.
– fundername: Takeda Science foundation
  grantid: Y.D.
– fundername: the Kobayashi Foundation for Cancer Research
  grantid: Y.D.
– fundername: the Naito Foundation
  grantid: Y.D.
GroupedDBID ---
0R~
123
2WC
53G
5VS
7X7
88E
8FE
8FG
8FH
8FI
8FJ
A8Z
AADQD
AAFWJ
AAHBH
AAYXX
ABDBF
ABUWG
ACGFO
ACIWK
ACPRK
ACUHS
AEGXH
AENEX
AFKRA
AFPKN
AFRAH
AFZYC
AIAGR
ALIPV
ALMA_UNASSIGNED_HOLDINGS
BENPR
BPHCQ
BVXVI
CCPQU
CITATION
CS3
D1I
DIK
DU5
E3Z
EBD
EMOBN
ESX
FYUFA
GROUPED_DOAJ
GX1
HH5
HMCUK
HYE
HZ~
I09
IAO
IHR
KQ8
LK8
M1P
MODMG
O-U
O9-
OK1
P2P
PHGZM
PHGZT
PIMPY
PQQKQ
PROAC
PSQYO
RPM
SV3
TR2
TUS
UKHRP
~8M
3V.
ABJCF
BBNVY
BHPHI
CGR
CUY
CVF
ECM
EIF
HCIFZ
KB.
M7P
M~E
NPM
PDBOC
7XB
8FK
AZQEC
DWQXO
K9.
PJZUB
PKEHL
PPXIY
PQEST
PQUKI
PRINS
7X8
5PM
PUEGO
ID FETCH-LOGICAL-c559t-295b790fc02a39f9827c06fb70c867f31e7f0b0768591285a1e5f9ad34ce21fd3
IEDL.DBID 7X7
ISSN 1420-3049
IngestDate Wed Aug 27 01:25:27 EDT 2025
Thu Aug 21 14:14:33 EDT 2025
Fri Jul 11 09:44:26 EDT 2025
Fri Jul 25 19:55:46 EDT 2025
Wed Feb 19 02:04:14 EST 2025
Thu Apr 24 23:09:07 EDT 2025
Tue Jul 01 01:17:07 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 2
Keywords stapled peptide
amphipathicity
antimicrobial peptides
helical structure
magainin 2
Language English
License https://creativecommons.org/licenses/by/4.0
Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c559t-295b790fc02a39f9827c06fb70c867f31e7f0b0768591285a1e5f9ad34ce21fd3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ORCID 0000-0001-7521-4861
0000-0001-6523-0649
OpenAccessLink https://www.proquest.com/docview/2479580002?pq-origsite=%requestingapplication%
PMID 33466998
PQID 2479580002
PQPubID 2032355
ParticipantIDs doaj_primary_oai_doaj_org_article_54313c8ebd78468ba8a0071048beccf9
pubmedcentral_primary_oai_pubmedcentral_nih_gov_7830303
proquest_miscellaneous_2479422542
proquest_journals_2479580002
pubmed_primary_33466998
crossref_primary_10_3390_molecules26020444
crossref_citationtrail_10_3390_molecules26020444
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 20210116
PublicationDateYYYYMMDD 2021-01-16
PublicationDate_xml – month: 1
  year: 2021
  text: 20210116
  day: 16
PublicationDecade 2020
PublicationPlace Switzerland
PublicationPlace_xml – name: Switzerland
– name: Basel
PublicationTitle Molecules (Basel, Switzerland)
PublicationTitleAlternate Molecules
PublicationYear 2021
Publisher MDPI AG
MDPI
Publisher_xml – name: MDPI AG
– name: MDPI
References Li (ref_9) 2020; 63
Chang (ref_4) 2015; 79
Sekiya (ref_16) 2018; 143
Nikaido (ref_3) 2009; 78
Porter (ref_7) 2000; 404
Zweytick (ref_13) 2006; 1758
Saigo (ref_18) 2019; 4
Akishiba (ref_21) 2017; 9
Li (ref_2) 2015; 58
Strandberg (ref_20) 2015; 21
ref_1
Lin (ref_14) 2015; 26
Yokoo (ref_10) 2020; 20
Goto (ref_5) 2019; 14
Walensky (ref_6) 2004; 305
Mourtada (ref_11) 2019; 37
Krishnakumari (ref_12) 2015; 199
Sekiya (ref_17) 2019; 2
Misawa (ref_19) 2019; 10
Yamashita (ref_15) 2016; 6
Ali (ref_8) 2019; 7
Kawano (ref_22) 2013; 3
References_xml – volume: 78
  start-page: 119
  year: 2009
  ident: ref_3
  article-title: Multidrug resistance in bacteria
  publication-title: Annu. Rev. Biochem.
  doi: 10.1146/annurev.biochem.78.082907.145923
– volume: 4
  start-page: 13124
  year: 2019
  ident: ref_18
  article-title: Electrophysiological analysis of antimicrobial peptides in diverse species
  publication-title: ACS Omega
  doi: 10.1021/acsomega.9b01033
– volume: 3
  start-page: 1995
  year: 2013
  ident: ref_22
  article-title: Automated parallel recordings of topologically identified single ion channels
  publication-title: Sci. Rep.
  doi: 10.1038/srep01995
– volume: 7
  start-page: 263
  year: 2019
  ident: ref_8
  article-title: Stapling peptides inhibitors: A new windows for target drug discovery
  publication-title: Comput. Struct. Biotechnol. J.
  doi: 10.1016/j.csbj.2019.01.012
– volume: 404
  start-page: 565
  year: 2000
  ident: ref_7
  article-title: Non-haemolytic-amino-acid oligomers
  publication-title: Nature
  doi: 10.1038/35007145
– volume: 26
  start-page: 71
  year: 2015
  ident: ref_14
  article-title: Dual peptide conjugation strategy for improved cellular uptake and mitochondria targeting
  publication-title: Bioconjug. Chem.
  doi: 10.1021/bc500408p
– volume: 58
  start-page: 4802
  year: 2015
  ident: ref_2
  article-title: Helical Antimicrobial Sulfono-γ-AApeptides
  publication-title: J. Med. Chem.
  doi: 10.1021/acs.jmedchem.5b00537
– volume: 63
  start-page: 4081
  year: 2020
  ident: ref_9
  article-title: Novel stapling by lysin tethering provides stable and low hemolytic cationic antimicrobial peptides
  publication-title: J. Med. Chem.
  doi: 10.1021/acs.jmedchem.9b02025
– volume: 1758
  start-page: 1426
  year: 2006
  ident: ref_13
  article-title: Influence of N-acylation of a peptide derived from human lactoferricin on membrane selectivity
  publication-title: Biochim. Biophys. Acta.
  doi: 10.1016/j.bbamem.2006.02.032
– volume: 9
  start-page: 751
  year: 2017
  ident: ref_21
  article-title: Cytosolic antibody delivery by lipid-sensitive endosomolytic peptide
  publication-title: Nat. Chem.
  doi: 10.1038/nchem.2779
– volume: 79
  start-page: 101
  year: 2015
  ident: ref_4
  article-title: Origin and Proliferation of multi-drug resistance in Bacterial pathogen
  publication-title: Microbiol. Biol. Rev.
  doi: 10.1128/MMBR.00039-14
– volume: 10
  start-page: 896
  year: 2019
  ident: ref_19
  article-title: Rational design of novel amphipathic antimicrobial peptides focused on distribution of cationic acid residues
  publication-title: MedChemComm.
  doi: 10.1039/C9MD00166B
– volume: 37
  start-page: 1186
  year: 2019
  ident: ref_11
  article-title: Design of stapled antimicrobial peptides that are stable, nontoxic, and kill antibiotic-resistant bacteria in mice
  publication-title: Nat. Biotechnol.
  doi: 10.1038/s41587-019-0222-z
– volume: 305
  start-page: 1466
  year: 2004
  ident: ref_6
  article-title: Activation of apoptosis in Vivo by a hydrocarbon stapled BH3 Helix
  publication-title: Science
  doi: 10.1126/science.1099191
– volume: 2
  start-page: 1542
  year: 2019
  ident: ref_17
  article-title: Electrophysiological analysis of membrane disruption by bombinin and its isomer using the lipid bilayer system
  publication-title: ACS Appl. Bio Mater.
  doi: 10.1021/acsabm.8b00835
– volume: 20
  start-page: 912
  year: 2020
  ident: ref_10
  article-title: De Novo design of cel-penetrating foldamers
  publication-title: Chem. Rec.
  doi: 10.1002/tcr.202000047
– volume: 143
  start-page: 3540
  year: 2018
  ident: ref_16
  article-title: Channel current analysis estimates the pore-formation and the penetration of transmembrane peptides
  publication-title: Analyst
  doi: 10.1039/C8AN00243F
– volume: 199
  start-page: 25
  year: 2015
  ident: ref_12
  article-title: N-Terminal fatty acylation of peptides spanning the cationic C-terminal segment of bovine -defensin-2 results in salt-resistant antibacterial activity
  publication-title: Biophys. Chem.
  doi: 10.1016/j.bpc.2015.02.005
– volume: 6
  start-page: 33003
  year: 2016
  ident: ref_15
  article-title: Development of a cell-penetrating peptide that exhibits responsive changes in its secondary structure in the cellular environment
  publication-title: Sci. Rep.
  doi: 10.1038/srep33003
– volume: 21
  start-page: 436
  year: 2015
  ident: ref_20
  article-title: Influence of hydrophobic residues on the activity of the antimicrobial peptide magainin 2 and its synergy with PGLa
  publication-title: J. Pept. Sci.
  doi: 10.1002/psc.2780
– ident: ref_1
  doi: 10.3390/ijms19103041
– volume: 14
  start-page: 1911
  year: 2019
  ident: ref_5
  article-title: Development of amphipathic antimicrobial peptide foldamers based on Magainin 2 sequence
  publication-title: ChemMedChem
  doi: 10.1002/cmdc.201900460
SSID ssj0021415
Score 2.485338
Snippet Magainin 2 (Mag2), which was isolated from the skin of the African clawed frog, is a representative antimicrobial peptide (AMP) that exerts antimicrobial...
Magainin 2 ( ), which was isolated from the skin of the African clawed frog, is a representative antimicrobial peptide (AMP) that exerts antimicrobial activity...
Magainin 2 ( Mag2 ), which was isolated from the skin of the African clawed frog, is a representative antimicrobial peptide (AMP) that exerts antimicrobial...
SourceID doaj
pubmedcentral
proquest
pubmed
crossref
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
StartPage 444
SubjectTerms Amino Acid Sequence
Amino acids
amphipathicity
Animals
Anti-Bacterial Agents - chemistry
Anti-Bacterial Agents - pharmacology
Antimicrobial agents
antimicrobial peptides
Aqueous solutions
Bacteria
Chromatography
Cytotoxicity
Drug resistance
Enzymes
Gram-negative bacteria
Gram-Negative Bacteria - growth & development
Gram-Positive Bacteria - growth & development
helical structure
Hydrocarbons
magainin 2
Magainins - chemistry
Magainins - pharmacology
Membranes
Peptides
stapled peptide
Xenopus laevis
Xenopus Proteins - chemistry
Xenopus Proteins - pharmacology
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3fa9swEBajL93LaLut9ZoWDfZUMJX1W49NaCiFlsFW6JuxZIkFEics6f_fO9sJSTval70Z64Tlu7O_O3T6jpAfIWokbXF5TAXPpUky90nGXHgVldPGiIDnne_u9c2DvH1Uj1utvrAmrKMH7hR3iWe1RbDR1wag0vrKVi0sSotPT-3RPcC8dTLVp1oF4FK3hykgqb-cda1m4xKid44MaTso1JL1_yvCfFkouYU84wPyqQ8Z6VW31EPyITZHZH-07tT2mdxuVf7QeaJXzWoym7QMSzAPwsnFNNb0J9av1HFJhwBcNZ03FMmlsT8E5fRXX1H9hTyMr3-PbvK-R0IeIBdY5dwpbxxLgfFKuOQsN4Hp5A0LVpskimgS87jdphxAkaqKqJKraiFD5EWqxVey18ybeEKo0lW0TDMHMYwEhXsPF3WCEDxpb3SVEbbWWRl6AnHsYzEtIZFANZev1JyRi82URcee8ZbwEA2xEUTi6_YGuEPZu0P5njtkZLA2Y9l_jcuSS-OUxZ9_Rr5vhsFIuDlSNXH-1MlI-LlJkDnurL5ZiRBSa8hLM2J2_GFnqbsjzeRPy9VtLMQITHz7H-92Sj5yrKhh2Np7QPZWf5_iGYREK3_eev8zJk4LbA
  priority: 102
  providerName: Directory of Open Access Journals
Title Development of Antimicrobial Stapled Peptides Based on Magainin 2 Sequence
URI https://www.ncbi.nlm.nih.gov/pubmed/33466998
https://www.proquest.com/docview/2479580002
https://www.proquest.com/docview/2479422542
https://pubmed.ncbi.nlm.nih.gov/PMC7830303
https://doaj.org/article/54313c8ebd78468ba8a0071048beccf9
Volume 26
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1La9wwEBZtcmgvJenTabKo0FPBRLbep5IN2YZAQ2gb2JuxZKldSOxtdvP_M2NrN9m05GKMJYPQjDTfaEbfEPLZB4WkLTYPsShzoaPIXRQh504GaZXW3ON95-_n6vRSnE3lNB24LVJa5WpP7DfqpvN4Rn5YCm2lwQX8df43x6pRGF1NJTSek22kLkOt1tN7h6sA6zREMjm49ofXQ8HZsAAMXyJP2oYt6in7_4czH6dLPrA_kx3yKgFHejRIepc8C-1r8uJ4Va_tDTl7kP9Du0iP2uXsetbzLMF_ACrnV6GhF5jF0oQFHYP5amjXUqSYxioRtKQ_U171W3I5Ofl1fJqnSgm5B49gmZdWOm1Z9KysuY3WlNozFZ1m3igdeRF0ZA6DbtKCQZJ1EWS0dcOFD2URG_6ObLVdGz4QKlUdDFPMApIRJjjn4KWJAMSjclrVGWGrOat8ohHHahZXFbgTOM3VP9OckS_rX-YDh8ZTnccoiHVHpL_uP3Q3v6u0miq8wM89jK7RgJ-Mq03dYyVhUCWjzcj-SoxVWpOL6l6DMvJp3QxCwhBJ3YbudugjYIsT0Of9IPX1SDgXSoF3mhG9oQ8bQ91saWd_esZubQApML739LA-kpclZswwLN29T7aWN7fhACDP0o16vYanmXwbke3xyfnFj1F_fHAH4zUGQQ
linkProvider ProQuest
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwEB6VcigXxJtAASPBBSmqYzt2fECoLSzbp5Bopd5CnNiwUpss3a0Qf4rfyEweSxdQb71FsR1ZnvHMN_H4G4BXpddE2mJjHxIRKxNU7ILysXSpT602RpZ03_ngUI-P1e5JerICv4a7MJRWOdjE1lBXTUn_yDeEMjbNaAO_m36PqWoUna4OJTQ6tdjzP39gyDZ7u_Me5ftaiNGHo-1x3FcViEtEz_NY2NQZy0PJRSFtsJkwJdfBGV5m2gSZeBO4owOq1KLxTovEp8EWlVSlF0moJH73BtxUEj053UwffVwEeAl6w-7kFBv5xllX4NbPMGYQxMu25PvaEgH_w7V_p2de8nejO3C7B6pss9Osu7Di63uwtj3Uh7sPu5fyjVgT2GY9n5xNWl4nHIcgdnrqK_aJsmYqP2Nb6C4r1tSMKK2pKgUT7HOfx_0Ajq9lDR_Cat3U_jGwVBc-45pbRE4q8845fKgCAv-gndFFBHxYs7zsacupesZpjuELLXP-zzJH8GYxZNpxdlzVeYsEsehIdNvti-b8a97v3pwIA2SJs6sM4rXMFVnRYjOV0RYINoL1QYx5bwNm-R-NjeDlohmFREcyRe2bi66PQpOqsM-jTuqLmUiptMZoOAKzpA9LU11uqSffWoZwkyEy4fLJ1dN6AWvjo4P9fH_ncO8p3BKUrcOpbPg6rM7PL_wzhFtz97zVcQZfrntT_QYyhz7m
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1bb9MwFD4anQS8IO4UBhgJXpCiurZjxw8IrbtoF6gqYNLesjixodKWlLUT4q_x6zgnl7IC2tveosaJLJ-Lv1OffB_A69xrIm2xkQ9DESkTVOSC8pF0sY-tNkbm9L3zx7HeO1IHx_HxGvzqvoWhtsouJ9aJuqhy-o98IJSxcUIBPAhtW8Rke_f97HtEClJ00trJaTQucuh__sDybf5ufxtt_UaI3Z0vW3tRqzAQ5YikF5GwsTOWh5yLTNpgE2FyroMzPE-0CXLoTeCODqtii4k8zoY-DjYrpMq9GIZC4ntvwLqhqqgH66Od8eTTstwb4t7YnKNKafngrJG79XOsIASxtK3shLVgwP9Q7t_Nmpd2v927cKeFrWyz8bN7sObL-3Brq1OLewAHl7qPWBXYZrmYnk1rlid8DiHt7NQXbEI9NIWfsxFungWrSkYE16RRwQT73HZ1P4Sja1nFR9Arq9I_ARbrzCdcc4s4SiXeOYcXRcAyIGhndNYH3q1Zmrck5qSlcZpiMUPLnP6zzH14u3xk1jB4XDV4RIZYDiTy7fqH6vxr2sZySvQBMsfZFQbRW-KyJKuRmkooIILtw0ZnxrTNCPP0j__24dXyNhqJDmiy0lcXzRiFCVbhmMeN1ZczkVJpjbVxH8yKP6xMdfVOOf1W84WbBHEKl0-vntZLuIkBlX7YHx8-g9uCWnc4aYhvQG9xfuGfI_ZauBetkzM4ue64-g0x30R4
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Development+of+Antimicrobial+Stapled+Peptides+Based+on+Magainin+2+Sequence&rft.jtitle=Molecules+%28Basel%2C+Switzerland%29&rft.au=Hirano%2C+Motoharu&rft.au=Saito%2C+Chihiro&rft.au=Yokoo%2C+Hidetomo&rft.au=Goto%2C+Chihiro&rft.date=2021-01-16&rft.issn=1420-3049&rft.eissn=1420-3049&rft.volume=26&rft.issue=2&rft_id=info:doi/10.3390%2Fmolecules26020444&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1420-3049&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1420-3049&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1420-3049&client=summon